January 2, 2005 -- In 2004, the problems mounted for big pharma, but several notable biotech drugs won FDA approval, giving more evidence of who is doing the best drug discovery. We discuss the shift in the balance of pharmaceutical power--never forgetting the ramifications as measured in stock prices--and look into 2005 as well.
